earnings season

ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also strategically positioned to capitalise on future...

In this episode, Marcus Today's Henry Jennings and Market Matters' James Gerrish analyse a handful of stocks that could surprise in August.

Plus, a closer look at how two of Livewire's most recognisable growth and value fund managers are investing.

10 of 11 major ASX sectors finished higher in a broad-based rally. Property and gold stocks led as the lithium short squeeze continues...

All the important stuff that happened on the Australian stock market today, all in one place.

Major brokers appreciated the strength of Fortescue's first half result, but it wasn’t enough to sway their prevailing bearish views.

It was another big day under the surface! While the S&P/ASX 200 gained just 0.12%, there were several massive earnings related moves.

All the important stuff that happened on the Australian stock market today, all in one place.

Pilbara is determined to be the best at what it can control so it’s ready for when the lithium price cycle turns.

All the important stuff that happened on the Australian stock market today, all in one place.

All the important stuff that happened on the Australian stock market today, all in one place.

Another sharp fall in iron ore in Asia today put pressure on BHP Group (BHP), Rio Tinto (RIO) and Fortescue (FMG).

Commonwealth Bank is widely considered Australia’s highest-quality banking operation, but it’s also considered the most overvalued.

It was another busy day in markets with earnings season delivering many more surprises, some good and some bad.

Earnings season is well and truly in full swing and already we're seeing the customary big swings in stock prices.

CSL's may have dipped the ASX 200 into the red, but there were several strong performances in technology and consumer discretionary stocks.

Aussie stocks closed modestly higher today as better than expected H1 FY24 results for AGL, Cochlear & News Corp saw them post strong gains.

The RBA was on hold today, and in many ways, so is the S&P/ASX 200's record breaking advance.

Analyst target price revisions show optimism towards health care & technology, and pessimism towards energy & telecommunications.

Earnings season can be a minefield and this season will be harder than most.